Flora Growth (FLGC) Competitors $1.05 +0.04 (+3.96%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends FLGC vs. CUE, ONCY, BYSI, VNRX, ATRA, SPRO, CNTB, MURA, IVVD, and AADIShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Cue Biopharma (CUE), Oncolytics Biotech (ONCY), BeyondSpring (BYSI), VolitionRx (VNRX), Atara Biotherapeutics (ATRA), Spero Therapeutics (SPRO), Connect Biopharma (CNTB), Mural Oncology (MURA), Invivyd (IVVD), and Aadi Bioscience (AADI). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. Cue Biopharma Oncolytics Biotech BeyondSpring VolitionRx Atara Biotherapeutics Spero Therapeutics Connect Biopharma Mural Oncology Invivyd Aadi Bioscience Cue Biopharma (NASDAQ:CUE) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, community ranking, institutional ownership, risk and dividends. Do insiders & institutionals have more ownership in CUE or FLGC? 35.0% of Cue Biopharma shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 12.3% of Cue Biopharma shares are held by insiders. Comparatively, 13.0% of Flora Growth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend CUE or FLGC? Cue Biopharma currently has a consensus price target of $5.00, indicating a potential upside of 395.05%. Flora Growth has a consensus price target of $5.00, indicating a potential upside of 376.19%. Given Cue Biopharma's stronger consensus rating and higher possible upside, research analysts plainly believe Cue Biopharma is more favorable than Flora Growth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cue Biopharma 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Flora Growth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the MarketBeat Community prefer CUE or FLGC? Cue Biopharma received 131 more outperform votes than Flora Growth when rated by MarketBeat users. However, 60.00% of users gave Flora Growth an outperform vote while only 52.33% of users gave Cue Biopharma an outperform vote. CompanyUnderperformOutperformCue BiopharmaOutperform Votes14652.33% Underperform Votes13347.67% Flora GrowthOutperform Votes1560.00% Underperform Votes1040.00% Is CUE or FLGC more profitable? Flora Growth has a net margin of -30.99% compared to Cue Biopharma's net margin of -468.02%. Cue Biopharma's return on equity of -156.38% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Cue Biopharma-468.02% -156.38% -88.07% Flora Growth -30.99%-268.17%-57.51% Which has higher earnings & valuation, CUE or FLGC? Cue Biopharma has higher earnings, but lower revenue than Flora Growth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCue Biopharma$9.53M6.71-$50.73M-$0.90-1.12Flora Growth$64.15M0.23-$57.04MN/AN/A Which has more risk and volatility, CUE or FLGC? Cue Biopharma has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.94, suggesting that its share price is 94% more volatile than the S&P 500. Does the media prefer CUE or FLGC? In the previous week, Cue Biopharma had 1 more articles in the media than Flora Growth. MarketBeat recorded 4 mentions for Cue Biopharma and 3 mentions for Flora Growth. Cue Biopharma's average media sentiment score of 1.67 beat Flora Growth's score of 0.88 indicating that Cue Biopharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cue Biopharma 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Flora Growth 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCue Biopharma beats Flora Growth on 9 of the 16 factors compared between the two stocks. Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.70M$6.57B$5.12B$9.07BDividend YieldN/A2.98%4.91%4.22%P/E RatioN/A10.5991.3417.19Price / Sales0.23195.381,116.63116.80Price / CashN/A57.1642.5837.86Price / Book1.355.104.794.78Net Income-$57.04M$151.51M$120.07M$225.60M7 Day Performance-19.23%-2.14%-1.90%-1.24%1 Month Performance-19.85%-3.13%11.43%3.06%1 Year Performance-21.64%11.51%30.59%16.50% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth3.0907 of 5 stars$1.05+4.0%$5.00+376.2%-20.5%$14.70M$64.15M0.00280Positive NewsGap DownHigh Trading VolumeCUECue Biopharma4.687 of 5 stars$1.03+9.6%$5.00+385.4%-63.1%$65.25M$9.53M-1.0360News CoveragePositive NewsGap UpONCYOncolytics Biotech1.9125 of 5 stars$0.82+1.2%$4.00+386.0%-33.0%$63.43MN/A-3.0030News CoverageBYSIBeyondSpringN/A$1.62-1.2%N/A+72.8%$63.23M$1.88M0.0080Positive NewsGap DownVNRXVolitionRx1.7538 of 5 stars$0.66+15.9%$3.75+472.5%+2.4%$60.70M$770,000.00-1.5780Gap UpATRAAtara Biotherapeutics3.8375 of 5 stars$10.38+0.5%$16.67+60.6%-17.6%$59.79M$100.44M-0.40165Analyst ForecastNews CoverageGap UpSPROSpero Therapeutics4.5453 of 5 stars$1.10+2.3%$5.00+356.6%-29.3%$59.70M$103.78M15.2946Analyst DowngradeNews CoverageCNTBConnect Biopharma3.4741 of 5 stars$1.08-3.4%$8.00+640.7%+11.9%$59.68M$24.12M0.00110Positive NewsGap DownMURAMural Oncology3.0898 of 5 stars$3.45-5.2%$16.00+363.8%-9.1%$58.72MN/A-0.40119Negative NewsGap UpIVVDInvivyd3.781 of 5 stars$0.49-10.7%$7.89+1,515.0%-87.0%$58.42M$11.56M-0.28100News CoverageGap DownAADIAadi Bioscience1.6327 of 5 stars$2.37-1.7%$1.67-29.7%+64.6%$58.41M$25.07M-1.0640News CoverageGap Up Related Companies and Tools Related Companies CUE Competitors ONCY Competitors BYSI Competitors VNRX Competitors ATRA Competitors SPRO Competitors CNTB Competitors MURA Competitors IVVD Competitors AADI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FLGC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
